Product innovation is fueling the industry’s growth. Typically, new medical products are developed to increase benefits for patients, to improve labor productivity, and to reduce patients’ hospital stays.
According to Standard & Poor’s manufacturers of cutting edge high tech medical technology will spend an average of 9-11% of annual revenues for research and development, versus an indicated national average of 3-4% of all US manufacturers.
Areas with such intensive R&D include cardio-vascular devices, such as stents or implantable defibrillators, orthopedic and orthodontic implants.
OUR CHALLENGE IN THE MEDICAL COMPONENT SUPPLY CHAIN
We will position ourselves as a supplier to the OEMs who are approved by the FDA (Food & Drug Administration) and evaluated as safe and effective.
|
|
